Ancora Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68.8K Sell
178
-236
-57% -$87.5K ﹤0.01% 986
2026
Q1
$121K Buy
414
+150
+57% +$49.3K ﹤0.01% 860
2025
Q4
$92.5K Buy
264
+132
+100% +$44.6K ﹤0.01% 940
2025
Q3
$42.7K Sell
132
-105
-44% -$32.7K ﹤0.01% 1068
2025
Q2
$92.2K Buy
237
+25
+12% +$10.1K ﹤0.01% 893
2025
Q1
$92.2K Buy
212
+2
+1% +$803 ﹤0.01% 878
2024
Q4
$77.5K Buy
210
+9
+4% +$3.77K ﹤0.01% 907
2024
Q3
$105K Buy
201
+2
+1% +$1.07K ﹤0.01% 811
2024
Q2
$108K Hold
199
﹤0.01% 786
2024
Q1
$103K Hold
199
﹤0.01% 800
2023
Q4
$93.8K Hold
199
﹤0.01% 810
2023
Q3
$86.6K Hold
199
﹤0.01% 808
2023
Q2
$88.4K Hold
199
﹤0.01% 799
2023
Q1
$91.5K Sell
199
-3
-1% -$1.43K ﹤0.01% 784
2022
Q4
$104K Buy
202
+46
+29% +$23.4K ﹤0.01% 818
2022
Q3
$71K Sell
156
-5
-3% -$2.39K ﹤0.01% 990
2022
Q2
$78K Buy
161
+45
+39% +$22.3K ﹤0.01% 1041
2022
Q1
$57K Buy
116
+13
+13% +$5.94K ﹤0.01% 1192
2021
Q4
$48K Hold
103
﹤0.01% 1302
2021
Q3
$38K Hold
103
﹤0.01% 1280
2021
Q2
$39K Sell
103
-4
-4% -$1.53K ﹤0.01% 1173
2021
Q1
$38K Buy
107
+4
+4% +$1.29K ﹤0.01% 1150
2020
Q4
$33K Sell
103
-6
-6% -$1.84K ﹤0.01% 970
2020
Q3
$29K Buy
109
+36
+49% +$9.69K ﹤0.01% 948
2020
Q2
$19K Hold
73
﹤0.01% 995
2020
Q1
$17K Hold
73
﹤0.01% 1084
2019
Q4
$22K Buy
+73
New +$20.1K ﹤0.01% 1047
2018
Q4
Sell
-102
Closed -$28K 771
2018
Q3
$28K Buy
+102
New +$26.5K ﹤0.01% 1009

Other funds holding ELV

Ancora Advisors's ELV Position: Q2 2026 in Review

Ancora Advisors reduced its Elevance Health (ELV) stake by 57% in Q2 2026, selling an estimated $87.5K and leaving 178 shares worth $68.8K. The position accounts for ﹤0.01% of the portfolio, ranked #986.

Ancora Advisors first reported a position in ELV in Q3 2018 and has held it in 28 quarters since. The position peaked at $121K in Q1 2026. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ancora Advisors held 178 shares of Elevance Health worth $68.8K as of Q2 2026.
  • Ancora Advisors sold 236 Elevance Health shares in Q2 2026, an estimated $87.5K.
  • Elevance Health made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #986 holding.
  • Ancora Advisors first reported a position in Elevance Health in Q3 2018 and has held it in 28 quarters since.
  • Ancora Advisors's Elevance Health position peaked at $121K in Q1 2026.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.